bioAffinity Technologies, Inc. (BIAF) Misses Q3 EPS by 465c

bioAffinity Technologies, Inc. (NASDAQ: BIAF) reported Q3 EPS of ($4.74), $4.65 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.45 million versus the consensus estimate of $1.55 million.

For earnings history and earnings-related data on bioAffinity Technologies, Inc. (BIAF) click here.

You May Also Be Interested In

• Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
• Ship traffic through Strait of Hormuz near three-month low
• Kenon Holdings (KEN) halted, news pending